-transparent.png){kind=logo}
Bumadizone-calcium-semihydrate and phenylbutazone were given orally to two groups (I and II) consisting of 6 persons each; plasma levels of bumadizone, phenylbutazone and oxyphenbutazone were determined over a period of 384 h. For bumadizone a plasma half-life of 6.9 h was found, maximum plasma levels were reached after 1-6 h varying from 27 to 46 microgram/ml. Phenylbutazone- and oxyphenbutazone-AUC-values were compared between the two groups.
Related Publications
H Spahn, and
E Mutschler, and
H E Geissler, and
G Faust-Tinnefeldt
January 1981,
Arzneimittel-Forschung,
H Spahn, and
E Mutschler, and
H E Geissler, and
G Faust-Tinnefeldt
January 1974,
European journal of clinical pharmacology,
H Spahn, and
E Mutschler, and
H E Geissler, and
G Faust-Tinnefeldt
October 1980,
La Nouvelle presse medicale,
H Spahn, and
E Mutschler, and
H E Geissler, and
G Faust-Tinnefeldt
January 1979,
Arzneimittel-Forschung,
H Spahn, and
E Mutschler, and
H E Geissler, and
G Faust-Tinnefeldt
December 1973,
Arzneimittel-Forschung,
H Spahn, and
E Mutschler, and
H E Geissler, and
G Faust-Tinnefeldt
September 1980,
La Nouvelle presse medicale,
H Spahn, and
E Mutschler, and
H E Geissler, and
G Faust-Tinnefeldt
May 1973,
Metabolism: clinical and experimental,
H Spahn, and
E Mutschler, and
H E Geissler, and
G Faust-Tinnefeldt
August 1977,
The British journal of venereal diseases,
H Spahn, and
E Mutschler, and
H E Geissler, and
G Faust-Tinnefeldt
March 1975,
Anaesthesia,
H Spahn, and
E Mutschler, and
H E Geissler, and
G Faust-Tinnefeldt
January 1982,
Therapie,
